In addition, chronically elevated IL-6 levels are associated with the formation and growth of several tumors such as breast cancer [52], making IL-6 a cancer marker, leading to a great need for novel IL-6-lowering cancer immunotherapy approaches [53, 54]. This evidence concerns the gene IL6 and breast cancer.